Some researchers administer the blend locally for tendon or joint-specific applications, while others use systemic administration for multi-site or whole-body recovery protocols
Originally proposed in HA-based micellar systems for tumor-targeted delivery, this mechanismspatial CD44-mediated localization of HA and ROS-triggered temporal GSH releaseis directly applicable to wound healing
cerevisiae W303-1b cells were transformed with the linearized recombinant plasmids to obtain engineered strains W303-1b/F/GAP, W303-1b/F/GAP, W303-1b/F/GAL1 and W303-1b/F/PGK1
Sayin VI, LeBoeuf SE, Singh SX, Davidson SM, Biancur D, Guzelhan BS, Alvarez SW, Wu WL, Karakousi TR, Zavitsanou AM, Ubriaco J, Muir A, Karagiannis D, Morris PJ, Thomas CJ, Possemato R, Vander Heiden MG, Papagiannakopoulos T